Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Receivables - Other (2022 - 2023)

Historic Receivables - Other for Lucid Diagnostics (LUCD) over the last 2 years, with Q2 2023 value amounting to $10.7 million.

  • Lucid Diagnostics' Receivables - Other rose 34038.7% to $10.7 million in Q2 2023 from the same period last year, while for Jun 2023 it was $10.7 million, marking a year-over-year increase of 34038.7%. This contributed to the annual value of $5.0 million for FY2022, which is N/A changed from last year.
  • As of Q2 2023, Lucid Diagnostics' Receivables - Other stood at $10.7 million, which was up 34038.7% from $7.6 million recorded in Q1 2023.
  • In the past 5 years, Lucid Diagnostics' Receivables - Other ranged from a high of $10.7 million in Q2 2023 and a low of $1.8 million during Q1 2022